{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["cardioprotection", "cardiovascular disorders", "drug development", "drug-likeness", "molecular mechanism", "tilianin"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35163934", "DateCompleted": {"Year": "2022", "Month": "02", "Day": "24"}, "DateRevised": {"Year": "2022", "Month": "02", "Day": "24"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "01", "Day": "20"}], "Language": ["eng"], "ELocationID": ["673", "10.3390/molecules27030673"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "27", "Issue": "3", "PubDate": {"Year": "2022", "Month": "Jan", "Day": "20"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "Tilianin: A Potential Natural Lead Molecule for New Drug Design and Development for the Treatment of Cardiovascular Disorders.", "Abstract": {"AbstractText": ["Cardiovascular disorders (CVDs) are the leading risk factor for death worldwide, and research into the processes and treatment regimens has received a lot of attention. Tilianin is a flavonoid glycoside that can be found in a wide range of medicinal plants and is most commonly obtained from <i>Dracocephalum moldavica</i>. Due to its extensive range of biological actions, it has become a well-known molecule in recent years. In particular, numerous studies have shown that tilianin has cardioprotective properties against CVDs. Hence, this review summarises tilianin's preclinical research in CVDs, as well as its mechanism of action and opportunities in future drug development. The physicochemical and drug-likeness properties, as well as the toxicity profile, were also highlighted. Tilianin can be a natural lead molecule in the therapy of CVDs such as coronary heart disease, angina pectoris, hypertension, and myocardial ischemia, according to scientific evidence. Free radical scavenging, inflammation control, mitochondrial function regulation, and related signalling pathways are all thought to play a role in tilianin's cardioprotective actions. Finally, we discuss tilianin-derived compounds, as well as the limitations and opportunities of using tilianin as a lead molecule in drug development for CVDs. Overall, the scientific evidence presented in this review supports that tilianin and its derivatives could be used as a lead molecule in CVD drug development initiatives."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, Faculty of Pharmacy and Health Sciences, Royal College of Medicine Perak, Universiti Kuala Lumpur, Ipoh 30450, Perak, Malaysia."}], "LastName": "Khattulanuar", "ForeName": "Farrah Syazana", "Initials": "FS"}, {"Identifier": ["0000-0002-3022-6137"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, Faculty of Pharmacy and Health Sciences, Royal College of Medicine Perak, Universiti Kuala Lumpur, Ipoh 30450, Perak, Malaysia."}], "LastName": "Sekar", "ForeName": "Mahendran", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Pharmacy, AIMST University, Bedong, Kedah 08100, Malaysia."}], "LastName": "Fuloria", "ForeName": "Shivkanya", "Initials": "S"}, {"Identifier": ["0000-0001-6470-3651"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, Monash University Malaysia, Bandar Sunway, Selangor 47500, Malaysia."}], "LastName": "Gan", "ForeName": "Siew Hua", "Initials": "SH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Pharmacy and Health Sciences, Royal College of Medicine Perak, Universiti Kuala Lumpur, Ipoh 30450, Perak, Malaysia."}], "LastName": "Rani", "ForeName": "Nur Najihah Izzati Mat", "Initials": "NNIM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry, Karpagam Academy of Higher Education, Coimbatore 641021, Tamil Nadu, India."}], "LastName": "Ravi", "ForeName": "Subban", "Initials": "S"}, {"Identifier": ["0000-0002-7981-4562"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, College of Pharmacy, King Khalid University, Abha 62529, Saudi Arabia."}], "LastName": "Chidambaram", "ForeName": "Kumarappan", "Initials": "K"}, {"Identifier": ["0000-0002-1871-8585"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutics, College of Pharmacy, King Khalid University, Abha 61421, Saudi Arabia."}], "LastName": "Begum", "ForeName": "M Yasmin", "Initials": "MY"}, {"Identifier": ["0000-0003-4874-1169"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Pharmacy, AIMST University, Bedong, Kedah 08100, Malaysia."}], "LastName": "Azad", "ForeName": "Abul Kalam", "Initials": "AK"}, {"Identifier": ["0000-0003-3514-7654"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Sri Ramachandra Faculty of Pharmacy, Sri Ramachandra Institute of Higher Education and Research (DU), Porur, Chennai 600116, Tamil Nadu, India."}], "LastName": "Jeyabalan", "ForeName": "Srikanth", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Sri Ramachandra Faculty of Pharmacy, Sri Ramachandra Institute of Higher Education and Research (DU), Porur, Chennai 600116, Tamil Nadu, India."}], "LastName": "Dhiravidamani", "ForeName": "Arulmozhi", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Center for Transdisciplinary Research, Department of Pharmacology, Saveetha Dental College and Hospital, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai 600077, India."}], "LastName": "Thangavelu", "ForeName": "Lakshmi", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, Faculty of Pharmacy and Health Sciences, Royal College of Medicine Perak, Universiti Kuala Lumpur, Ipoh 30450, Perak, Malaysia."}], "LastName": "Lum", "ForeName": "Pei Teng", "Initials": "PT"}, {"Identifier": ["0000-0002-9629-9494"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Medicine, Bioscience and Nursing, MAHSA University, Jalan SP 2, Bandar Saujana Putra, Jenjarom 42610, Selangor, Malaysia."}], "LastName": "Subramaniyan", "ForeName": "Vetriselvan", "Initials": "V"}, {"Identifier": ["0000-0001-5574-8049"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Centre for Virus and Vaccine Research, School of Medical and Life Sciences, Sunway University, Subang Jaya 47500, Malaysia."}, {"Identifier": [], "Affiliation": "Department of Biological Sciences, School of Medical and Life Sciences, Sunway University, Subang Jaya 47500, Malaysia."}], "LastName": "Wu", "ForeName": "Yuan Seng", "Initials": "YS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Applied Sciences, AIMST University, Bedong, Kedah 08100, Malaysia."}], "LastName": "Sathasivam", "ForeName": "Kathiresan V", "Initials": "KV"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Pharmacy, AIMST University, Bedong, Kedah 08100, Malaysia."}], "LastName": "Fuloria", "ForeName": "Neeraj Kumar", "Initials": "NK"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Biological Products"}, {"RegistryNumber": "0", "NameOfSubstance": "Flavonoids"}, {"RegistryNumber": "0", "NameOfSubstance": "Glycosides"}, {"RegistryNumber": "0", "NameOfSubstance": "tilianin"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Biological Products"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Cardiovascular Diseases"}, {"QualifierName": [], "DescriptorName": "Drug Design"}, {"QualifierName": [], "DescriptorName": "Drug Development"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Flavonoids"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Glycosides"}, {"QualifierName": [], "DescriptorName": "Humans"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "WHO  Cardiovascular Diseases.  [(accessed on 24 September 2021)].  Available online:  https://www.who.int/health-topics/cardiovascular-diseases#tab=tab_1."}, {"Citation": "Benjamin E.J., Virani S.S., Callaway C.W., Chamberlain A.M., Chang A.R., Cheng S., Chiuve S.E., Cushman M., Delling F.N., Deo R. Heart disease and stroke statistics\u20142018 update: A report from the American Heart Association. Circulation. 2018;137:e67\u2013e492. doi: 10.1161/CIR.0000000000000558.", "ArticleIdList": ["10.1161/CIR.0000000000000558", "29386200"]}, {"Citation": "Hausenloy D.J., Yellon D.M. Cardioprotection (Oxford Cardiology Library) Oxford University Press; Oxford, UK: 2009."}, {"Citation": "Sajid M., Cameotra S.S., Khan M.S.A., Ahmad I. New Look to Phytomedicine. Elsevier; Amsterdam, The Netherlands: 2019. Nanoparticle-based delivery of phytomedicines: Challenges and opportunities; pp. 597\u2013623."}, {"Citation": "Casertano M., Menna M., Imperatore C. The ascidian-derived metabolites with antimicrobial properties. Antibiotics. 2020;9:510. doi: 10.3390/antibiotics9080510.", "ArticleIdList": ["10.3390/antibiotics9080510", "PMC7460354", "32823633"]}, {"Citation": "Ros\u00e9n J., Gottfries J., Muresan S., Backlund A., Oprea T.I. Novel chemical space exploration via natural products. J. Med. Chem. 2009;52:1953\u20131962. doi: 10.1021/jm801514w.", "ArticleIdList": ["10.1021/jm801514w", "PMC2696019", "19265440"]}, {"Citation": "Ooi B.K., Chan K.-G., Goh B.H., Yap W.H. The role of natural products in targeting cardiovascular diseases via Nrf2 pathway: Novel molecular mechanisms and therapeutic approaches. Front. Pharmacol. 2018;9:1308. doi: 10.3389/fphar.2018.01308.", "ArticleIdList": ["10.3389/fphar.2018.01308", "PMC6249275", "30498447"]}, {"Citation": "Cragg G.M., Newman D.J. Natural products: A continuing source of novel drug leads. Biochim. Biophys. Acta (BBA)-Gen. Subj. 2013;1830:3670\u20133695. doi: 10.1016/j.bbagen.2013.02.008.", "ArticleIdList": ["10.1016/j.bbagen.2013.02.008", "PMC3672862", "23428572"]}, {"Citation": "Ntie-Kang F., Svozil D. An enumeration of natural products from microbial, marine and terrestrial sources. Phys. Sci. Rev. 2020;5:20180121. doi: 10.1515/psr-2018-0121.", "ArticleIdList": ["10.1515/psr-2018-0121"]}, {"Citation": "Hern\u00e1ndez-Abreu O., Torres-Piedra M., Garc\u00eda-Jim\u00e9nez S., Ibarra-Barajas M., Villalobos-Molina R., Montes S., Rembao D., Estrada-Soto S. Dose-dependent antihypertensive determination and toxicological studies of tilianin isolated from Agastache mexicana. J. Ethnopharmacol. 2013;146:187\u2013191. doi: 10.1016/j.jep.2012.12.029.", "ArticleIdList": ["10.1016/j.jep.2012.12.029", "23276782"]}, {"Citation": "Wei J., Cao P., Wang J., Kang W. Analysis of tilianin and acacetin in Agastache rugosa by high-performance liquid chromatography with ionic liquids-ultrasound based extraction. Chem. Cent. J. 2016;10:76. doi: 10.1186/s13065-016-0223-7.", "ArticleIdList": ["10.1186/s13065-016-0223-7", "PMC5127089", "27994640"]}, {"Citation": "Garc\u00eda-D\u00edaz J.A., Navarrete-V\u00e1zquez G., Garc\u00eda-Jim\u00e9nez S., Hidalgo-Figueroa S., Almanza-P\u00e9rez J.C., Alarc\u00f3n-Aguilar F.J., G\u00f3mez-Zamudio J., Cruz M., Ibarra-Barajas M., Estrada-Soto S. Antidiabetic, antihyperlipidemic and anti-inflammatory effects of tilianin in streptozotocin-nicotinamide diabetic rats. Biomed. Pharmacother. 2016;83:667\u2013675. doi: 10.1016/j.biopha.2016.07.023.", "ArticleIdList": ["10.1016/j.biopha.2016.07.023", "27470567"]}, {"Citation": "Nam K.-H., Choi J.-H., Seo Y.-J., Lee Y.-M., Won Y.-S., Lee M.-R., Lee M.-N., Park J.-G., Kim Y.-M., Kim H.-C. Inhibitory effects of tilianin on the expression of inducible nitric oxide synthase in low density lipoprotein receptor deficiency mice. Exp. Mol. Med. 2006;38:445\u2013452. doi: 10.1038/emm.2006.52.", "ArticleIdList": ["10.1038/emm.2006.52", "16953124"]}, {"Citation": "Oh H.M., Kang Y.J., Lee Y.S., Park M.K., Kim S.H., Kim H.J., Seo H.G., Lee J.H., Chang K.C. Protein kinase G-dependent heme oxygenase-1 induction by Agastache rugosa leaf extract protects RAW264. 7 cells from hydrogen peroxide-induced injury. J. Ethnopharmacol. 2006;103:229\u2013235. doi: 10.1016/j.jep.2005.08.030.", "ArticleIdList": ["10.1016/j.jep.2005.08.030", "16185832"]}, {"Citation": "Gonzalez-Trujano M.E., Ponce-Mu\u00f1oz H., Hidalgo-Figueroa S., Navarrete-V\u00e1zquez G., Estrada-Soto S. Depressant effects of Agastache mexicana methanol extract and one of major metabolites tilianin. Asian Pac. J. Trop. Med. 2015;8:185\u2013190. doi: 10.1016/S1995-7645(14)60312-6.", "ArticleIdList": ["10.1016/S1995-7645(14)60312-6", "25902158"]}, {"Citation": "Jiang H., Fang J., Xing J., Wang L., Wang Q., Wang Y., Li Z., Liu R. Tilianin mediates neuroprotection against ischemic injury by attenuating CaMKII-dependent mitochondrion-mediated apoptosis and MAPK/NF-\u03baB signaling. Life Sci. 2019;216:233\u2013245. doi: 10.1016/j.lfs.2018.11.035.", "ArticleIdList": ["10.1016/j.lfs.2018.11.035", "30472297"]}, {"Citation": "Zeng C., Jiang W., Zheng R., He C., Li J., Xing J. Cardioprotection of tilianin ameliorates myocardial ischemia-reperfusion injury: Role of the apoptotic signaling pathway. PLoS ONE. 2018;13:e0193845. doi: 10.1371/journal.pone.0193845.", "ArticleIdList": ["10.1371/journal.pone.0193845", "PMC5851616", "29538428"]}, {"Citation": "G\u00e1lvez J., Estrada-Reyes R., Ben\u00edtez-King G., Araujo G., Orozco S., Fern\u00e1ndez-Mas R., Almaz\u00e1n S., Calixto E. Involvement of the GABAergic system in the neuroprotective and sedative effects of acacetin 7-O-glucoside in rodents. Restor. Neurol. Neurosci. 2015;33:683\u2013700. doi: 10.3233/RNN-140486.", "ArticleIdList": ["10.3233/RNN-140486", "PMC4923766", "26410208"]}, {"Citation": "Greiser K.H., Kluttig A., Schumann B., Kors J.A., Swenne C.A., Kuss O., Werdan K., Haerting J. Cardiovascular disease, risk factors and heart rate variability in the elderly general population: Design and objectives of the CARdiovascular disease, Living and Ageing in Halle (CARLA) Study. BMC Cardiovasc. Disord. 2005;5:33. doi: 10.1186/1471-2261-5-33.", "ArticleIdList": ["10.1186/1471-2261-5-33", "PMC1299322", "16283930"]}, {"Citation": "Pashkow F.J. Oxidative stress and inflammation in heart disease: Do antioxidants have a role in treatment and/or prevention? Int. J. Inflamm. 2011;2011:514623. doi: 10.4061/2011/514623.", "ArticleIdList": ["10.4061/2011/514623", "PMC3157078", "21860805"]}, {"Citation": "Jiang H., Zeng L., Dong X., Guo S., Xing J., Li Z., Liu R. Tilianin extracted from Dracocephalum moldavica L. induces intrinsic apoptosis and drives inflammatory microenvironment response on pharyngeal squamous carcinoma cells via regulating TLR4 signaling pathways. Front. Pharmacol. 2020;11:205. doi: 10.3389/fphar.2020.00205.", "ArticleIdList": ["10.3389/fphar.2020.00205", "PMC7064631", "32194422"]}, {"Citation": "Tian L., Cao W., Yue R., Yuan Y., Guo X., Qin D., Xing J., Wang X. Pretreatment with Tilianin improves mitochondrial energy metabolism and oxidative stress in rats with myocardial ischemia/reperfusion injury via AMPK/SIRT1/PGC-1 alpha signaling pathway. J. Pharmacol. Sci. 2019;139:352\u2013360. doi: 10.1016/j.jphs.2019.02.008.", "ArticleIdList": ["10.1016/j.jphs.2019.02.008", "30910451"]}, {"Citation": "Wang Y., Yuan Y., Wang X., Wang Y., Cheng J., Tian L., Guo X., Qin D., Cao W. Tilianin post-conditioning attenuates myocardial ischemia/reperfusion injury via mitochondrial protection and inhibition of apoptosis. Med. Sci. Monit. Int. Med. J. Exp. Clin. Res. 2017;23:4490. doi: 10.12659/MSM.903259.", "ArticleIdList": ["10.12659/MSM.903259", "PMC5614336", "28922345"]}, {"Citation": "Guo X., Cao W., Yao J., Yuan Y., Hong Y., Wang X., Xing J. Cardioprotective effects of tilianin in rat myocardial ischemia-reperfusion injury. Mol. Med. Rep. 2015;11:2227\u20132233. doi: 10.3892/mmr.2014.2954.", "ArticleIdList": ["10.3892/mmr.2014.2954", "25405380"]}, {"Citation": "Yuan Y., Cao W., Hong Y., Guo X., Wang Y., Wang Y., Wang X., Hu P. Tilianin pretreatment prevents myocardial ischemia-reperfusion injury via preservation of mitochondrial function in rat heart. Phytomedicine. 2017;34:106\u2013114. doi: 10.1016/j.phymed.2017.08.007.", "ArticleIdList": ["10.1016/j.phymed.2017.08.007", "28899492"]}, {"Citation": "Yao J., Li Y., Jin Y., Chen Y., Tian L., He W. Synergistic cardioptotection by tilianin and syringin in diabetic cardiomyopathy involves interaction of TLR4/NF-\u03baB/NLRP3 and PGC1a/SIRT3 pathways. Int. Immunopharmacol. 2021;96:107728. doi: 10.1016/j.intimp.2021.107728.", "ArticleIdList": ["10.1016/j.intimp.2021.107728", "33971494"]}, {"Citation": "Castellon X., Bogdanova V. Chronic inflammatory diseases and endothelial dysfunction. Aging Dis. 2016;7:81. doi: 10.14336/AD.2015.0803.", "ArticleIdList": ["10.14336/AD.2015.0803", "PMC4723236", "26815098"]}, {"Citation": "Nam K.-w., Kim J., Hong J.-J., Choi J.-H., Mar W., Cho M.-H., Kim Y.-M., Oh S.-R., Lee H.-k., Nam K.-H. Inhibition of cytokine-induced I\u03baB kinase activation as a mechanism contributing to the anti-atherogenic activity of tilianin in hyperlipidemic mice. Atherosclerosis. 2005;180:27\u201335. doi: 10.1016/j.atherosclerosis.2004.11.022.", "ArticleIdList": ["10.1016/j.atherosclerosis.2004.11.022", "15823272"]}, {"Citation": "Shen W., Anwaier G., Cao Y., Lian G., Chen C., Liu S., Tuerdi N., Qi R. Atheroprotective mechanisms of tilianin by inhibiting inflammation through down-regulating NF-\u03baB pathway and foam cells formation. Front. Physiol. 2019;10:825. doi: 10.3389/fphys.2019.00825.", "ArticleIdList": ["10.3389/fphys.2019.00825", "PMC6614704", "31333487"]}, {"Citation": "Cao W., Hu N., Yuan Y., Cheng J., Guo X., Wang Y., Wang X., Hu P. Effects of tilianin on proliferation, migration and TGF-\u03b2/smad signaling in rat vascular smooth muscle cells induced with angiotensin II. Phytother. Res. 2017;31:1240\u20131248. doi: 10.1002/ptr.5846.", "ArticleIdList": ["10.1002/ptr.5846", "28620995"]}, {"Citation": "Israili Z.H., Hern\u00e1ndez-Hern\u00e1ndez R., Valasco M. The future of antihypertensive treatment. Am. J. Ther. 2007;14:121\u2013134. doi: 10.1097/01.pap.0000249915.12185.58.", "ArticleIdList": ["10.1097/01.pap.0000249915.12185.58", "17414579"]}, {"Citation": "Chobanian A.V., Bakris G.L., Black H.R., Cushman W.C., Green L.A., Izzo J.L., Jr., Jones D.W., Materson B.J., Oparil S., Wright J.T., Jr. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension. 2003;42:1206\u20131252. doi: 10.1161/01.HYP.0000107251.49515.c2.", "ArticleIdList": ["10.1161/01.HYP.0000107251.49515.c2", "14656957"]}, {"Citation": "Finlay B.B., Falkow S. Free-form 3-D surface description in multiple scales. Microbiol. Mol. Biol. Rev. 1997;61:136\u2013169.", "ArticleIdList": ["PMC232605", "9184008"]}, {"Citation": "Hern\u00e1ndez-Abreu O., Castillo-Espa\u00f1a P., Le\u00f3n-Rivera I., Ibarra-Barajas M., Villalobos-Molina R., Gonz\u00e1lez-Christen J., Vergara-Galicia J., Estrada-Soto S. Antihypertensive and vasorelaxant effects of tilianin isolated from Agastache mexicana are mediated by NO/cGMP pathway and potassium channel opening. Biochem. Pharmacol. 2009;78:54\u201361. doi: 10.1016/j.bcp.2009.03.016.", "ArticleIdList": ["10.1016/j.bcp.2009.03.016", "19447223"]}, {"Citation": "Carmona-Castro G., Estrada-Soto S., Arellano-Garc\u00eda J., Arias-Duran L., Valencia-D\u00edaz S., Perea-Arango I. High accumulation of tilianin in in-vitro cultures of Agastache mexicana and its potential vasorelaxant action. Mol. Biol. Rep. 2019;46:1107\u20131115. doi: 10.1007/s11033-018-4570-4.", "ArticleIdList": ["10.1007/s11033-018-4570-4", "30554312"]}, {"Citation": "Hern\u00e1ndez-Abreu O., Dur\u00e1n-G\u00f3mez L., Best-Brown R., Villalobos-Molina R., Rivera-Leyva J., Estrada-Soto S. Validated liquid chromatographic method and analysis of content of tilianin on several extracts obtained from Agastache mexicana and its correlation with vasorelaxant effect. J. Ethnopharmacol. 2011;138:487\u2013491. doi: 10.1016/j.jep.2011.09.041.", "ArticleIdList": ["10.1016/j.jep.2011.09.041", "21982792"]}, {"Citation": "Tang L., El-Din T.M.G., Swanson T.M., Pryde D.C., Scheuer T., Zheng N., Catterall W.A. Structural basis for inhibition of a voltage-gated Ca2+ channel by Ca2+ antagonist drugs. Nature. 2016;537:117\u2013121. doi: 10.1038/nature19102.", "ArticleIdList": ["10.1038/nature19102", "PMC5161592", "27556947"]}, {"Citation": "Deedwania P. The Role of Angiotensin Receptor Blockers in Cardiovascular Protection Beyond Blood Pressure Control. US Cardiol. 2006;3:37\u201339. doi: 10.15420/usc.2006.3.2.37.", "ArticleIdList": ["10.15420/usc.2006.3.2.37"]}, {"Citation": "Asada H., Inoue A., Kadji F.M.N., Hirata K., Shiimura Y., Im D., Shimamura T., Nomura N., Iwanari H., Hamakubo T. The crystal structure of angiotensin II type 2 receptor with endogenous peptide hormone. Structure. 2020;28:418\u2013425.e4. doi: 10.1016/j.str.2019.12.003.", "ArticleIdList": ["10.1016/j.str.2019.12.003", "31899086"]}, {"Citation": "Hahn V.S., Zhang K.W., Sun L., Narayan V., Lenihan D.J., Ky B. Heart failure with targeted cancer therapies: Mechanisms and cardioprotection. Circ. Res. 2021;128:1576\u20131593. doi: 10.1161/CIRCRESAHA.121.318223.", "ArticleIdList": ["10.1161/CIRCRESAHA.121.318223", "PMC8765442", "33983833"]}, {"Citation": "Wiseman D.N., Samra N., Rom\u00e1n Lara M.M., Penrice S.C., Goddard A.D. The Novel Application of Geometric Morphometrics with Principal Component Analysis to Existing G Protein-Coupled Receptor (GPCR) Structures. Pharmaceuticals. 2021;14:953. doi: 10.3390/ph14100953.", "ArticleIdList": ["10.3390/ph14100953", "PMC8541025", "34681177"]}, {"Citation": "Bitencourt-Ferreira G., de Azevedo W.F. Docking Screens for Drug Discovery. Springer; Berlin/Heidelberg, Germany: 2019. Molegro virtual docker for docking; pp. 149\u2013167.", "ArticleIdList": ["31452104"]}, {"Citation": "EPA . User\u2019s Guide for T.E.S.T. (version 5.1) (Toxicity Estimation Software Tool): A Program to Estimate Toxicity from Molecular Structure. EPA; Cincinnati, OH, USA: 2020."}, {"Citation": "Yuan Y., Wang X., Chen W., Hong Y., Chen Q. Pharmacokinetics and bioavailability of tilianin microemulsion in rats. Chin. J. Hosp. Pharm. 2015;35:1815\u20131819."}, {"Citation": "NIPER  Drug Likeness Tool (DruLiTo)  [(accessed on 24 September 2021)]; Available online:  http://www.niper.gov.in/pi_dev_tools/DruLiToWeb/DruLiTo_Reference.html."}, {"Citation": "Wang Y., Wang Y., Wang X., Hu P. Tilianin-loaded reactive oxygen species-scavenging nano-micelles protect H9c2 cardiomyocyte against hypoxia/reoxygenation-induced injury. J. Cardiovasc. Pharmacol. 2018;72:32\u201339. doi: 10.1097/FJC.0000000000000587.", "ArticleIdList": ["10.1097/FJC.0000000000000587", "29688912"]}, {"Citation": "Zieli\u0144ska S., Matkowski A. Phytochemistry and bioactivity of aromatic and medicinal plants from the genus Agastache (Lamiaceae) Phytochem. Rev. 2014;13:391\u2013416. doi: 10.1007/s11101-014-9349-1.", "ArticleIdList": ["10.1007/s11101-014-9349-1", "PMC4032471", "24899872"]}, {"Citation": "Lee H.W., Ryu H.W., Baek S.C., Kang M.-G., Park D., Han H.-Y., An J.H., Oh S.-R., Kim H. Potent inhibitions of monoamine oxidase A and B by acacetin and its 7-O-(6-O-malonylglucoside) derivative from Agastache rugosa. Int. J. Biol. Macromol. 2017;104:547\u2013553. doi: 10.1016/j.ijbiomac.2017.06.076.", "ArticleIdList": ["10.1016/j.ijbiomac.2017.06.076", "28634060"]}, {"Citation": "Chaurasiya N.D., Zhao J., Pandey P., Doerksen R.J., Muhammad I., Tekwani B.L. Selective inhibition of human monoamine oxidase B by acacetin 7-methyl ether isolated from turnera diffusa (Damiana) Molecules. 2019;24:810. doi: 10.3390/molecules24040810.", "ArticleIdList": ["10.3390/molecules24040810", "PMC6412401", "30813423"]}, {"Citation": "Yu N., He C., Awuti G., Zeng C., Xing J., Huang W. Simultaneous determination of six active compounds in Yixin Badiranjibuya granules, a traditional Chinese medicine, by RP-HPLC-UV method. J. Anal. Methods Chem. 2015;2015:974039. doi: 10.1155/2015/974039.", "ArticleIdList": ["10.1155/2015/974039", "PMC4637494", "26587308"]}, {"Citation": "Mas-Capdevila A., Teichenne J., Domenech-Coca C., Caimari A., Del Bas J.M., Escot\u00e9 X., Crescenti A. Effect of hesperidin on cardiovascular disease risk factors: The role of intestinal microbiota on hesperidin bioavailability. Nutrients. 2020;12:1488. doi: 10.3390/nu12051488.", "ArticleIdList": ["10.3390/nu12051488", "PMC7284956", "32443766"]}, {"Citation": "Chang W., Wu Q.-Q., Xiao Y., Jiang X.-H., Yuan Y., Zeng X.-F., Tang Q.-Z. Acacetin protects against cardiac remodeling after myocardial infarction by mediating MAPK and PI3K/Akt signal pathway. J. Pharmacol. Sci. 2017;135:156\u2013163. doi: 10.1016/j.jphs.2017.11.009.", "ArticleIdList": ["10.1016/j.jphs.2017.11.009", "29276114"]}, {"Citation": "Bonferoni M.C., Rossi S., Sandri G., Ferrari F. Nanoparticle formulations to enhance tumor targeting of poorly soluble polyphenols with potential anticancer properties. Semin. Cancer Biol. 2017;46:205\u2013214. doi: 10.1016/j.semcancer.2017.06.010.", "ArticleIdList": ["10.1016/j.semcancer.2017.06.010", "28673607"]}, {"Citation": "Lagoa R., Silva J., Rodrigues J.R., Bishayee A. Advances in phytochemical delivery systems for improved anticancer activity. Biotechnol. Adv. 2020;38:107382. doi: 10.1016/j.biotechadv.2019.04.004.", "ArticleIdList": ["10.1016/j.biotechadv.2019.04.004", "30978386"]}, {"Citation": "Rahimi H.R., Nedaeinia R., Shamloo A.S., Nikdoust S., Oskuee R.K. Novel delivery system for natural products: Nano-curcumin formulations. Avicenna J. Phytomedicine. 2016;6:383.", "ArticleIdList": ["PMC4967834", "27516979"]}, {"Citation": "Siddiqui I.A., Sanna V. Impact of nanotechnology on the delivery of natural products for cancer prevention and therapy. Mol. Nutr. Food Res. 2016;60:1330\u20131341. doi: 10.1002/mnfr.201600035.", "ArticleIdList": ["10.1002/mnfr.201600035", "26935239"]}, {"Citation": "Wang S., Su R., Nie S., Sun M., Zhang J., Wu D., Moustaid-Moussa N. Application of nanotechnology in improving bioavailability and bioactivity of diet-derived phytochemicals. J. Nutr. Biochem. 2014;25:363\u2013376. doi: 10.1016/j.jnutbio.2013.10.002.", "ArticleIdList": ["10.1016/j.jnutbio.2013.10.002", "PMC3959237", "24406273"]}, {"Citation": "Pistollato F., Bremer-Hoffmann S., Basso G., Cano S.S., Elio I., Vergara M.M., Giampieri F., Battino M. Targeting glioblastoma with the use of phytocompounds and nanoparticles. Target. Oncol. 2016;11:1\u201316. doi: 10.1007/s11523-015-0378-5.", "ArticleIdList": ["10.1007/s11523-015-0378-5", "26275397"]}, {"Citation": "Zuraini N.Z.A., Sekar M., Wu Y.S., Gan S.H., Bonam S.R., Rani N.N.I.M., Begum M.Y., Lum P.T., Subramaniyan V., Fuloria N.K. Promising nutritional fruits against cardiovascular diseases: An overview of experimental evidence and understanding their mechanisms of action. Vasc. Health Risk Manag. 2021;17:739\u2013769. doi: 10.2147/VHRM.S328096.", "ArticleIdList": ["10.2147/VHRM.S328096", "PMC8631183", "34858028"]}, {"Citation": "Yap K.M., Sekar M., Fuloria S., Wu Y.S., Gan S.H., Rani N.N.I.M., Subramaniyan V., Kokare C., Lum P.T., Begum M.Y. Drug delivery of natural products through nanocarriers for effective breast cancer therapy: A comprehensive review of literature. Int. J. Nanomed. 2021;16:7891\u20137941. doi: 10.2147/IJN.S328135.", "ArticleIdList": ["10.2147/IJN.S328135", "PMC8648329", "34880614"]}, {"Citation": "Davatgaran-Taghipour Y., Masoomzadeh S., Farzaei M.H., Bahramsoltani R., Karimi-Soureh Z., Rahimi R., Abdollahi M. Polyphenol nanoformulations for cancer therapy: Experimental evidence and clinical perspective. Int. J. Nanomed. 2017;12:2689. doi: 10.2147/IJN.S131973.", "ArticleIdList": ["10.2147/IJN.S131973", "PMC5388197", "28435252"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "12", "Day": "28"}, {"Year": "2022", "Month": "1", "Day": "17"}, {"Year": "2022", "Month": "1", "Day": "18"}, {"Year": "2022", "Month": "2", "Day": "15", "Hour": "1", "Minute": "19"}, {"Year": "2022", "Month": "2", "Day": "16", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "2", "Day": "25", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "1", "Day": "20"}], "PublicationStatus": "epublish", "ArticleIdList": ["35163934", "PMC8838974", "10.3390/molecules27030673", "molecules27030673"]}}], "PubmedBookArticle": []}